Annual Current Liabilities
$1.83 M
+$10.90 K+0.60%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual total current liabilities is $1.83 million, with the most recent change of +$10.90 thousand (+0.60%) on September 30, 2024.
- During the last 3 years, EDSA annual current liabilities has risen by +$374.10 thousand (+25.65%).
- EDSA annual current liabilities is now -52.69% below its all-time high of $3.87 million, reached on August 31, 2013.
Performance
EDSA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.83 M
-$527.80 K-22.36%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly total current liabilities is $1.83 million, with the most recent change of -$527.80 thousand (-22.36%) on September 30, 2024.
- Over the past year, EDSA quarterly current liabilities has dropped by -$317.90 thousand (-14.78%).
- EDSA quarterly current liabilities is now -67.60% below its all-time high of $5.66 million, reached on June 30, 2022.
Performance
EDSA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
EDSA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.6% | -14.8% |
| 3 y3 years | +25.6% | +19.9% |
| 5 y5 years | +297.1% | +19.9% |
EDSA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | +25.6% | -67.6% | +43.1% |
| 5 y | 5-year | -14.4% | +297.1% | -67.6% | +216.6% |
| alltime | all time | -52.7% | -100.0% | -67.6% | -100.0% |
Edesa Biotech Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $1.83 M(+0.6%) | $1.83 M(-22.4%) |
| Jun 2024 | - | $2.36 M(+9.8%) |
| Mar 2024 | - | $2.15 M(+8.2%) |
| Dec 2023 | - | $1.99 M(+9.1%) |
| Sep 2023 | $1.82 M(-14.9%) | $1.82 M(+19.2%) |
| Jun 2023 | - | $1.53 M(-2.3%) |
| Mar 2023 | - | $1.56 M(+22.2%) |
| Dec 2022 | - | $1.28 M(-40.2%) |
| Sep 2022 | $2.14 M(+46.8%) | $2.14 M(-62.2%) |
| Jun 2022 | - | $5.66 M(+69.6%) |
| Mar 2022 | - | $3.34 M(+90.9%) |
| Dec 2021 | - | $1.75 M(+19.8%) |
| Sep 2021 | $1.46 M(-4.7%) | $1.46 M(+48.3%) |
| Jun 2021 | - | $983.50 K(-78.7%) |
| Mar 2021 | - | $4.62 M(+409.8%) |
| Dec 2020 | - | $906.30 K(-40.8%) |
| Sep 2020 | $1.53 M(+231.4%) | $1.53 M(+55.6%) |
| Jun 2020 | - | $983.10 K(+69.8%) |
| Mar 2020 | - | $578.90 K(-17.8%) |
| Dec 2019 | - | $704.20 K(-30.6%) |
| Sep 2019 | $461.60 K(-6.4%) | - |
| Jun 2019 | - | $1.01 M(+15.2%) |
| Mar 2019 | - | $881.40 K(+48.9%) |
| Dec 2018 | - | $592.00 K(+20.0%) |
| Sep 2018 | $493.40 K(+53.8%) | $493.40 K(+19.0%) |
| Jun 2018 | - | $414.60 K(-29.7%) |
| Mar 2018 | - | $589.80 K(+2.7%) |
| Dec 2017 | - | $574.40 K(+79.0%) |
| Sep 2017 | $320.90 K | $320.90 K(-24.5%) |
| Jun 2017 | - | $425.30 K(-1.9%) |
| Mar 2017 | - | $433.40 K(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | - | $602.10 K(-3.4%) |
| Sep 2016 | $623.60 K(-73.8%) | $623.60 K(-25.7%) |
| Jun 2016 | - | $839.00 K(+36.2%) |
| Mar 2016 | - | $616.10 K(-14.9%) |
| Dec 2015 | - | $723.70 K(-69.6%) |
| Sep 2015 | $2.38 M(+254.2%) | $2.38 M(+33.7%) |
| Jun 2015 | - | $1.78 M(-38.7%) |
| Mar 2015 | - | $2.90 M(-26.6%) |
| Dec 2014 | - | $3.96 M(+178.4%) |
| Sep 2014 | $672.20 K(-52.7%) | - |
| Aug 2014 | $1.42 M(-63.3%) | $1.42 M(+39.1%) |
| May 2014 | - | $1.02 M(-42.0%) |
| Feb 2014 | - | $1.76 M(-2.4%) |
| Nov 2013 | - | $1.81 M(-53.4%) |
| Aug 2013 | $3.87 M(+589.2%) | $3.87 M(+1041.8%) |
| May 2013 | - | $339.30 K(-23.7%) |
| Feb 2013 | - | $444.80 K(-21.0%) |
| Nov 2012 | - | $562.80 K(+0.1%) |
| Aug 2012 | $562.10 K(+253.3%) | $562.10 K(+52.8%) |
| May 2012 | - | $367.80 K(+18.5%) |
| Feb 2012 | - | $310.50 K(-39.8%) |
| Nov 2011 | - | $516.20 K(+224.5%) |
| Aug 2011 | $159.10 K(-62.2%) | $159.10 K(+20.1%) |
| May 2011 | - | $132.50 K(-1.1%) |
| Feb 2011 | - | $134.00 K(-71.2%) |
| Nov 2010 | - | $464.90 K(+10.5%) |
| Aug 2010 | $420.60 K(>+9900.0%) | $420.60 K(+268.9%) |
| May 2010 | - | $114.00 K(+125.7%) |
| Jan 2010 | - | $50.50 K(+268.6%) |
| Oct 2009 | - | $13.70 K(>+9900.0%) |
| Apr 2009 | $0.00(-100.0%) | $0.00 |
| Apr 2008 | $9400.00 | - |
FAQ
- What is Edesa Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Edesa Biotech?
- What is Edesa Biotech annual current liabilities year-on-year change?
- What is Edesa Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Edesa Biotech?
- What is Edesa Biotech quarterly current liabilities year-on-year change?
What is Edesa Biotech annual total current liabilities?
The current annual current liabilities of EDSA is $1.83 M
What is the all time high annual current liabilities for Edesa Biotech?
Edesa Biotech all-time high annual total current liabilities is $3.87 M
What is Edesa Biotech annual current liabilities year-on-year change?
Over the past year, EDSA annual total current liabilities has changed by +$10.90 K (+0.60%)
What is Edesa Biotech quarterly total current liabilities?
The current quarterly current liabilities of EDSA is $1.83 M
What is the all time high quarterly current liabilities for Edesa Biotech?
Edesa Biotech all-time high quarterly total current liabilities is $5.66 M
What is Edesa Biotech quarterly current liabilities year-on-year change?
Over the past year, EDSA quarterly total current liabilities has changed by -$317.90 K (-14.78%)